Abstract
Obesity is a serious public health concern and a major risk factor for metabolic syndrome, type 2 diabetes mellitus and various cardiovascular diseases. In the present study, we assess the real-world effectiveness of a digital therapeutic in influencing lifestyle modification to encourage weight loss in patients with obesity and metabolic syndrome.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
